LumiEso Stent Esophageal System

Designed with biocompatible materials, this advanced stent system provides effective support for esophageal strictures, ensuring sustained luminal patency and improved swallowing function in patients with esophageal obstructions.

LumiEso Stent Esophageal System is an innovative, self-expanding stent solution engineered to reestablish and maintain esophageal patency in patients with malignant or benign strictures. Crafted with advanced nitinol or hybrid alloys and featuring precision deployment mechanics, LumiEso stents foster reliable decompression under endoscopic or fluoroscopic guidance—promoting improved ingestion, quality of life, and reduced procedure times in everyday clinical practice.

Key Features & Technology

High-Radial-Force Stent Construction
  • Durable Nitinol/Hybrid Alloy: Supplies continuous radial expansion to support stenotic segments, resisting the dynamic pressures of esophageal peristalsis.
  • Flexible Architecture: Conforms to the esophagus’ curvature, reducing patient discomfort and risk of stent migration.
  • Low-Profile System: Designed for smooth passage through narrow strictures.
  • Gradual Unveiling Mechanism: Offers careful positioning, minimizing the risk of misplacement and enabling partial recapture if a reposition is necessary (model-specific).
  • Enhanced Imaging: Distinct markers at the stent’s proximal and distal ends ensure exact alignment with the stricture edges.
  • Real-Time Visualization: Under endoscopic or fluoroscopic guidance, these markers help operators confirm final stent coverage.
  • Flared Ends or Anchoring Loops: Stabilize the stent in high motility sections of the esophagus, mitigating the risk of distal or proximal migration.
  • Coatings (some models): May include polyurethane or silicone coatings to inhibit tumor ingrowth and maintain a smooth inner lumen.

Clinical Applications & Benefits

Malignant & Benign Strictures
  • Esophageal Cancer or External Compression: palliative relief of dysphagia, enhancing nutritional intake and patient comfort.
  • Benign Conditions: e.g., peptic strictures, anastomotic strictures—temporary stenting can allow tissue healing or bridging until further therapy.
  • Endoscopic or Fluoroscopic Placement: Reduces morbidity compared to open surgical bypass, accelerating recovery and minimizing hospital stay.
  • Immediate Symptom Relief: Restores esophageal lumen patency, alleviating dysphagia and allowing better hydration/nutrition.
  • Robust Radial Force: Ensures the stent consistently dilates the stricture, often decreasing repeated procedures for stent blockage or displacement.
  • Tissue-Sparing: Avoids large incisions or extensive tissue resection, preserving esophageal function as feasible.
  • Enhanced Oral Intake: Patients may resume more normal diets shortly after stent insertion.
  • Palliative & Bridge-to-Surgery: With malignant pathologies, stenting extends comfortable life expectancy; for others, it supports a phased approach to eventual definitive therapy.